Corporate social responsibility for nanotechnology oversight

Jennifer Kuzma, Aliya Kuzhabekova

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is strengthened by the adoption of stakeholder-driven models and attention to moral principles in policies and programs. In this context, we examine drivers of CSR, contextual and leadership factors that influence CSR, and strategies for CSR. To illustrate these concepts, we discuss existing cases of CSR-like behavior in nanotechnology companies, and then provide examples of how companies producing nanomedicines can exhibit morally-driven CSR behavior.

Original languageEnglish
Pages (from-to)407-419
Number of pages13
JournalMedicine, Health Care and Philosophy
Issue number4
Publication statusPublished - Nov 2011


  • Corporate social responsibility
  • Nanotechnology
  • Oversight

ASJC Scopus subject areas

  • Health(social science)
  • Education
  • Health Policy

Fingerprint Dive into the research topics of 'Corporate social responsibility for nanotechnology oversight'. Together they form a unique fingerprint.

Cite this